Interferon alfacon-1
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 00:53, 28 May 2016. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 00:53, 28 May 2016 by Vanished user 0x8cSXE0x6 (talk | contribs)
Clinical data | |
---|---|
Routes of administration | Parenteral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
DrugBank |
|
ChemSpider |
|
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C860H1353N227O255S9 |
Molar mass | 19343 g/mol g·mol−1 |
NY (what is this?) (verify) |
Interferon alfacon-1 is a recombinant synthetic type I interferon used for the treatment of hairy cell leukemia, malignant melanoma and AIDS-related Kaposi's sarcoma.[1]
References
Endogenous |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exogenous |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Articles with changed DrugBank identifier
- Chemicals that do not have a ChemSpider ID assigned
- Chem-molar-mass both hardcoded and calculated
- Infobox-drug molecular-weight unexpected-character
- Infobox drug articles without a structure image
- Articles without EBI source
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes which contain changes to verified fields
- All stub articles